Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative anxiety after dilation and curettage in IVF patients with missed abortion
ChiCTR2400080537Phase 4Recruiting
- Sponsor
- Sichuan Jinxin Xinan Women and Children Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in anxiety disorder and major depressive disorder (MDD) (4 arms), sponsored by Sichuan Jinxin Xinan Women and Children Hospital. Primary endpoints: Incidence of anxiety and Pregnancy outcomes. Started Feb 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2400080537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080537.